Literature DB >> 15383169

Antimicrobial susceptibility patterns of Arcobacter butzleri and Arcobacter cryaerophilus strains isolated from humans and broilers.

Kurt Houf1, Luc A Devriese, Freddy Haesebrouck, Olivier Vandenberg, Jean-Paul Butzler, Jan van Hoof, Peter Vandamme.   

Abstract

The MICs of five antimicrobial agents were determined by the agar dilution method for 98 Arcobacter butzleri and 28 Arcobacter cryaerophilus strains from humans, and poultry. With gentamicin, a MIC of 16 microg/ml was recorded for one A. butzleri strain isolated from poultry, whereas for the other strains MICs ranged from 0.25 to 4 microg/ml. With ciprofloxacin, a bimodal distribution of susceptibility levels was seen for human A. butzleri isolates (0.015-0.03 versus 0.12-0.25), whereas MICs for 65 of the 68 A. butzleri poultry strains ranged from 0.12 to 0.5 microg/ml and three strains from three different broilers were resistant with a MIC of 16 microg/ml. One A. cryaerophilus strain from poultry was resistant to erythromycin at a MIC of 128 microg/ml, whereas MICs for the other Arcobacter strains ranged from 2 to 32 microg/ml. No difference in susceptibility or resistance among the human and poultry strains tested was observed with doxycycline and nalidixic acid. The presence of acquired resistance to erythromycin and ciprofloxacin among poultry isolates is a matter of concern, because the two antimicrobials are generally prescribed as first-line drugs for the treatment of infections with Campylobacteraceae in humans. Copyright Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383169     DOI: 10.1089/mdr.2004.10.243

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

1.  Arcobacter in Lake Erie beach waters: an emerging gastrointestinal pathogen linked with human-associated fecal contamination.

Authors:  Cheonghoon Lee; Senyo Agidi; Jason W Marion; Jiyoung Lee
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

Review 2.  Taxonomy, epidemiology, and clinical relevance of the genus Arcobacter.

Authors:  Luis Collado; Maria José Figueras
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Regulation of energy metabolism by the extracytoplasmic function (ECF) σ factors of Arcobacter butzleri.

Authors:  Irati Martinez-Malaxetxebarria; Rudy Muts; Linda van Dijk; Craig T Parker; William G Miller; Steven Huynh; Wim Gaastra; Jos P M van Putten; Aurora Fernandez-Astorga; Marc M S M Wösten
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

4.  Genotyping, antibiotic resistance and prevalence of Arcobacter species in milk and dairy products.

Authors:  Abazar Lameei; Ebrahim Rahimi; Amir Shakerian; Hassan Momtaz
Journal:  Vet Med Sci       Date:  2022-04-14

5.  Accumulation and expression of multiple antibiotic resistance genes in Arcobacter cryaerophilus that thrives in sewage.

Authors:  Jess A Millar; Rahul Raghavan
Journal:  PeerJ       Date:  2017-04-25       Impact factor: 2.984

6.  Characterization of Arcobacter strains isolated from human stool samples: results from the prospective German prevalence study Arcopath.

Authors:  Markus M Heimesaat; Greta Gölz; Vanessa Brückner; Ulrike Fiebiger; Ralf Ignatius; Johannes Friesen; Martin Eisenblätter; Marlies Höck; Thomas Alter; Stefan Bereswill
Journal:  Gut Pathog       Date:  2020-01-08       Impact factor: 4.181

7.  Characterization of Arcobacter spp. Isolated from human diarrheal, non-diarrheal and food samples in Thailand.

Authors:  Paksathorn Kietsiri; Chonchanok Muangnapoh; Woradee Lurchachaiwong; Paphavee Lertsethtakarn; Ladaporn Bodhidatta; Orasa Suthienkul; Norman C Waters; Samandra T Demons; Brian A Vesely
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

8.  The Effect of Antibiotics on Planktonic Cells and Biofilm Formation Ability of Collected Arcobacter-like Strains and Strains Isolated within the Czech Republic.

Authors:  Karolína Švarcová; Marcela Pejchalová; David Šilha
Journal:  Antibiotics (Basel)       Date:  2022-01-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.